Company News 13 Jun 2022 Heart Attack Data Presented In Berlin Implicit Bioscience will be in the spotlight this week at the world congress of the International Society for Heart Research… Implicit Bioscience
Company News 08 Nov 2021 IC14 featured in Medicine Journal The US scientific journal Medicine has published a report of the first safety and biomarker study of IC14 in patients with ALS-MND.… Implicit Bioscience
Company News Implicit Bioscience 26 May 2021 Taming the Immune System in COVID-19 and other Serious Diseases The following feature story was written by an experienced biotechnology market commentator in the US, following an interview with Implicit… Implicit Bioscience
Company News 16 Apr 2021 Media Release: IC14 COVID-19 US Clinical Trial Implicit Bioscience is pleased to announce the commencement of its IC14 COVID-19 clinical trials in the US. Implicit Bioscience
Company News 12 Jan 2021 FDA Awards IC14 as Orphan Drug for MND The FDA has designated Brisbane biotech Implicit Bioscience’s biologic IC14 an Orphan Drug for the treatment of motor neurone disease. Implicit Bioscience
Company News 20 Dec 2020 US Defense Department Funds Program for IC14 in Neurotrauma The US Department of Defense has funded a USD 735,000 grant entitled “Danger Signalling, Traumatic Brain Injury (TBI), and Epileptogenesis”. Implicit Bioscience
Company News 15 Dec 2020 FDA Grants Approval for Heart Attack Trial The US Food and Drug Administration has issued a “Study May Proceed” letter approving the commencement of clinical study with… Implicit Bioscience
Company News 30 Sep 2020 Landmark Publication Points to IC14 Target in ALS-MND ALS-MND is our leading clinical program in neurodegeneration; however Parkinson’s and Alzheimer’s disease are also coming into sharp focus with… Implicit Bioscience
Company News 03 Jun 2020 FDA approves COVID-19 study On June 3, the US FDA approved an Investigative New Drug (IND) application for IC14 together with remdesivir in 300… Implicit Bioscience
Company News 16 Dec 2019 New research links IC14 target to dementia New research published in the world’s leading journal Neurology reports a link between higher levels of an inflammatory marker called sCD14 and… Implicit Bioscience
